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ABSTRACT: Microfluidic platforms offer a drastic increase in
throughput while minimizing sample usage and hands-on time,
which make them important tools for large-scale biological studies.
A range of such systems have been developed for enzyme activity
studies, although their complexity largely hinders their application
to the wider scientific community. Here, we present adaptation of
an easy-to-use commercial microfluidic qPCR system for perform-
ing enzyme kinetic studies. We demonstrate the functionality of
the Fluidigm Biomark HD system (the Fluidigm system) by
determining the kinetic properties of three oxidases in a resorufin-based fluorescence assay. The results obtained in the microfluidic
system proved reproducible and comparable to the ones obtained in a standard microplate-based assay. With a wide range of easy-to-
use, off-the-shelf components, the microfluidic system presents itself as a simple and customizable platform for high-throughput
enzyme activity studies.
■ INTRODUCTION
In the past decade, we have witnessed a drastic increase in
genomic data being deposited in public databases, which
provides the potential for the discovery of new enzymatic
activities and a deeper understanding of the known ones.1−3
However, the current experimental methods cannot keep up
with the characterization of novel genes, resulting in a chronic
lack of validated data in public databases.4 Currently, the most
common methods for in-depth enzyme characterization rely on
manual preparation of enzyme−substrate mixtures in a
microplate, which is time-consuming and requires large
amounts of proteins and substrates. This usually result in a
limited range of conditions and substrates being tested and
hinder the exploration of enzymatic potential of a protein. A
number of high-throughput methods have been developed for
both end-point and kinetic measurements of enzyme
activity;5−7 however, their adaptation by the wider scientific
community proves difficult, as it requires specialized knowl-
edge and access to microfluidic manufacturing facilities.8 A
simple method for performing enzyme kinetic studies in readily
available high-throughput off-the-shelf devices would help to
address this problem.
Although no high-throughput microfluidic devices for
measuring enzyme kinetics are commercially available, such
instruments were developed for real-time qPCR applica-
tions.9,10 One such system was established by Fluidigm
Corporation, where gene expression analysis is carried out in
integrated fluidic circuit chips, with a setup that offers an
increase in throughput and reduction in sample volumes, yet
remaining user-friendly.11 In the Fluidigm system, samples and
reagents are first pressure-loaded into nanoliter-sized reaction
chambers of the chip, which is then transferred to a real-time
PCR instrument designed to thermal cycle the microfluidic
chips and image the data in real time. The Fluidigm ecosystem,
including a number of different chips and a range of available
fluorescent filters (Table S1), indicates its potential for novel
applications, in addition to qPCR. In this work, we show that a
qPCR microfluidic system can be easily adapted for enzyme
kinetic studies with improved throughput and decreased
sample usage over conventional methods.
■ RESULTS
Characterization of Experimental Platform: a Micro-
fluidic qPCR Device for Enzymatic Assays. To assess the
suitability of the Fluidigm system for enzyme activity
screening, we chose a FlexSix Gene Expression IFC chip
which contains six partitions, each with 12 wells on the assay
side and 12 wells on the sample side (Figure 1A). The chip
provides a medium range of throughput: from 144 up to 864
reactions per chip, depending on how samples are routed in
the chip. As a model enzyme, we selected the hydrogen
peroxide-producing enzyme lactate oxidase (LOX, EC 1.1.3.2).
The activity of lactate oxidase can be detected using a simple
coupled fluorescence assay, in which a nonfluorescent probe
Received: October 8, 2020
Accepted: December 21, 2020
Published: January 13, 2021
Articlehttp://pubs.acs.org/journal/acsodf




ACS Omega 2021, 6, 1985−1990
This is an open access article published under a Creative Commons Attribution (CC-BY)
License, which permits unrestricted use, distribution and reproduction in any medium,





































































































reacts with hydrogen peroxide to produce a fluorescent
product, resorufin (Figure S1).
We first tested over what range resorufin fluorescence was
linear in the Fluidigm system by measuring a range of resorufin
concentrations. Our results indicated that it is possible to
capture the linear response for up to 5 μM of resorufin, which
is comparable to data obtained in a microplate reader (Figure
S2). Next, we asked whether enzyme activity could be captured
in the system and measured the increase of fluorescence over
time for different enzyme concentrations with 5 mM lactate.
To lower the adhesion of protein to the chip’s channels and
minimize protein precipitation, we tested two concentrations
of nonionic detergents in a buffer, in the presence or absence
of BSA. Additionally, we used the fluorescein dye as a loading
control to inspect whether the mixing of the sample is
consistent throughout the chip. The results showed that we
were able to not only detect the activity of the enzyme but also
capture its initial reaction rates (Figure 1B). Addition of BSA
did not influence the results, while a higher concentration of
detergents provided more consistent signal readouts through-
out replicates but resulted in much higher overall background
fluorescence (Figure S3). Readouts of the fluorescent signal
from the fluorescein loading control indicate equal sample
loading throughout the chip, with higher detergent concen-
trations leading to more reproducible loading (Figure S4).
Overall, the results of the initial screen show the potential of
the Fluidigm system for measuring the enzyme activity.
Measurement of Enzyme Kinetics in the Fluidigm
Microfluidic System. Next, we evaluated whether the
Fluidigm system is reliable for studying enzymatic Michae-
lis−Menten kinetics. To test this, we measured the initial
reaction rates of three hydrogen peroxide-producing enzymes:
lactate oxidase, glucose oxidase (EC 1.1.3.4), and glutamate
oxidase (EC 1.4.3.11). For each of the three oxidases, 5
different enzyme concentrations were placed in duplicate on
the assay side of the FlexSix chip and 11 substrate
Figure 1. Exploration of the Fluidigm gene expression system as a platform for enzyme activity measurements. (A) Schematic representation of a
FlexSix microfluidic chip. (B) Example of the obtained initial reaction rates of lactate oxidase in reaction with lactate in a buffer with composition
0.01% Triton-X-100 and Tween 20 and addition of BSA. (C) Experimental setup for measurements of enzyme kinetic parameters in the Biomark
HD system. Schematic overview of enzyme loading with 6 different concentrations (blue) in the “assay” input wells and loading of the substrate
with 12 different concentrations (magenta) in the “sample” input wells. (D) Schematic overview of the sample/assay gradient that results from the
all vs all mixing that occurs in the FlexSix chip. All enzyme concentrations are mixed with all substrate concentrations. In the illustrated scheme, two
technical duplicates of each enzyme concentration are run. (E) Example of resorufin fluorescence intensity values recorded in the run. Here, for
lactate oxidase, it is carried out at cycle 60.
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concentrations were placed on the sample side (Figure 1C).
During sample loading, in each partition, all enzyme samples
were separately mixed with all substrate samples, creating an
enzyme−substrate gradient (Figure 1D,E). The use of different
enzyme concentrations enabled capturing kinetic information
in one run only, without the need of previous knowledge of
enzyme activity. The final enzyme concentrations were
between 9.6 ng/mL and 6 μg/mL and the final substrate
concentrations were between 1.7 μM and 100 mM. To enable
rapid analysis of this data, we developed R-scripts which
automatically identify the enzyme concentration for which
initial rates are linear, fit a linear regression model to those data
points, and extract the slope.
When establishing a new method, it is of key importance to
validate it. We therefore set out to test the system’s
reproducibility as well as accuracy. In order to test the
reproducibility of the system, we repeated the assay for each
enzyme three times using three different FlexSix chips. The
obtained kinetic parameters of the three replicates were highly
similar (Table 1, Figure 2), indicating outstanding reproduci-
bility of the method. As a validation of system’s accuracy, we
compared the results obtained in the Fluidigm system with the
ones obtained from assays performed in a standard 384-well
plate with the signal recorded in a fluorescent plate reader
(Table 1, Figure 2). The values obtained in the microfluidic
chip are comparable with the ones obtained in a plate reader
and reported in the literature (Table 1). The largest difference
in the obtained results is between Vmax values of glucose
oxidase (microplate: 2.4 μmol mg−1 min−1; chip: 23 μmol
mg−1 min−1), most likely due to enzyme stock dependency,
which is supported by the fact that the range of Vmax reported
in the literature is very broad (6−170 μmol mg−1 min−1).
Overall, the results show that the performance of the Fluidigm
system in measuring enzyme kinetics is on par, in terms of data
quality, with that of a standard plate system used routinely
today.
■ DISCUSSION
In this work, we show that a microfluidic qPCR system can be
applied in biochemistry without modification and is suitable
for determining enzyme kinetic parameters. Although we have
only tested one microfluidic system in this work, the method
can likely be adapted to systems from other manufacturers.
The Fluidigm system offers the well-known advantages of
microfluidic devices over conventional methods: increase of
throughput and drastic reduction in both reagent volumes
used, as well as manual handling time involved in performing
experiments.5 Using only half the capacity of the smallest
Fluidigm chip, it was possible to establish reliable kinetic values
for three different enzymes in one run (432 reactions), whereas
three separate runs had to be performed using microplates for
validation comparison. Mixing of the enzyme and the substrate
is performed automatically in the microfluidic chip, which
reduces the manual handling required, while the reaction
volume also decreased over 2000-fold (from 20 μL to 8.9 nL).
Like many microfluidic devices, the Fluidigm system used
here comes with the drawback of only being suitable for
fluorescence-based assays, which limits the type of enzyme
activities that could potentially be monitored. This, however, is
becoming less of an issue with an increase of new fluorescent
enzyme screens being developed.13 The majority of micro-
fluidic systems for measuring enzyme kinetics allow creating a
wide concentration gradient of substrate in a programmable
manner,7 which results in much higher precision in comparison
to standard methods. In the Fluidigm system, a limited number
of substrate dilutions are prepared by hand, similarly to a
standard microplate assay, which lowers the precision and
increases the chance of manual-handling error. However, the
system presented in this work provides a clear advantage over
the previously described methods: low system complexity,
which allows users to operate it with commercially available
equipment and software, without a fluid handling expertise.
This is an important advantage, as the lack of easy to use,
standardized systems is a major cause for low adaptation of
microfluidics by nonspecialists such as biochemists.8 Although
high-throughput qPCR systems such as Fluidigm are not yet
common in a standard laboratory, they are becoming
increasingly accessible as the need for gene expression analysis
continues to grow and new genomic core facilities are being
established.
A further advantage of the system over the existing
microfluidic devices is that it allows parallelization of many
enzyme kinetic measurements at the same time, with the
possibility of testing different enzymes, substrates, and
conditions in a single run. Availability of many easy to use,
off-the-shelf chips makes the Fluidigm system a good platform
for different experiment designs for enzyme screening. The
system allows for both smaller scale experiments in FlexSix
IFCs and larger scale ones, all-versus-all studies using the larger
96.96 IFC; where up to 9216 separate reactions can be
performed simultaneously. In our study, we present the
successful use of one type of chip and two fluorescent probes:
resorufin and fluorescein, which present a potential of the
system for testing a wide range of enzymes such as
oxidoreductases, phosphatases, proteases, galactosidases, or
deadenylases. However, in order to explore the full potential of
the system, additional experiments with a wider range of chips,
enzymatic activities, and substrates would be required. We
believe that adapting a microfluidic gene expression system for
measuring enzyme activity can facilitate the growing need for
in-depth, yet high-throughput characterization of enzymes.
■ MATERIALS
The Flex Six Gene Expression IFC (product number 100-
6308) and Control Line Fluid Kit (product number
89000021) were purchased from Fluidigm Corporation,
Table 1. Comparison of Kinetic Values of Three Oxidases
Obtained in the Fluidigm System and a Microplate Reader




lactate oxidase Microplate 1.62 ± 0.48 22.00 ± 1.15
Chip 1.23 ± 0.12 23.67 ± 2.73
Literatureb 0.5−1 114−270
glutamate oxidase Microplate 0.20 ± 0.01 6.30 ± 0.25
Chip 0.29 ± 0.08 7.30 ± 1.00
Literatureb 0.17−0.3 6−55
glucose oxidase Microplate 20.67 ± 2.72 2.40 ± 0.00
Chip 16.33 ± 1.76 23.00 ± 4.58
Literatureb 22−32 6−170
aValues for the microplate and the chip represent the mean average
(±standard error of mean; n = 3). bLiterature values ranges, as
reported for wild-type enzymes in BRENDA DB.12
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United States. All enzymes and chemicals were purchased from
Sigma Aldrich, unless stated otherwise.
■ METHODS
Fluidigm System Setup. The Flex Six Gene Expression
IFC was used for all microfluidic experiments. The Flex Six
chip has a total of six partitions which can be run either
independently or simultaneously. Each partition has a 12 × 12
format, in which solutions from 12 assay inlets are mixed with
solutions from 12 sample inlets in a 1:9 ratio. The final
reaction volume is 8.9 nL. Samples placed in the assay inlets
were prepared as 10× concentrations and solutions placed in
the sample inlets were prepared as 1.1× concentrations. Before
the first use of each IFC, the chips were primed with the
Control Line Fluid Kit in Juno System (Fluidigm, United
States) according to manufacturer’s guidelines. To load the
IFC, barrier plugs were removed from the partitions in use, and
3 μL each of assay and sample was pipetted into their
respective inlets. Caution was taken not to introduce air
bubbles while pipetting. Next, the IFC was placed in the Juno
machine and the “Load Mix Flex Six GE” was run. Immediately
after the loading script was finished, the IFC was transferred to
a Biomark HD machine (Fluidigm, United States) and data
collection protocol was set up using Fluidigm’s Data Collection
Figure 2. Comparison of kinetic values obtained in the Fluidigm system and a plate reader. Michaelis−Menten curves of three repeats in each
system for the three tested oxidases: (A) Lactate oxidase. (B) Glutamate oxidase. (C) Glucose oxidase.
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Software. After selecting partitions for the run, the “Gene
Expression” application type was chosen, ROX was chosen as
the “passive reference” (excitation filter: 575 nm; emission
filter: 630 nm) and FAM-MGB as the “probe” (excitation
filter: 475 nm; emission filter: 525 nm). The ROX channel was
used to collect the signal from resorufin, and FAM-MGB was
used to collect the signal from fluorescein-loading control,
which is the inverse of what is done in a typical qPCR
experiment. The chip run protocol was loaded and exposure
was set to 0.03 s for ROX and 2 s for FAM. The chip run
protocol was created using Fluidigm’s Real-Time PCR Analysis
Software: measurements were taken every 30 s for 30 min, at
25 °C. After the run was finished, the IFC was placed in Juno
and the “Post Run Flex Six GE’’ script was run in order to relax
the valves.
Enzyme Assays in the Fluidigm Platform. All enzyme
assays were performed in a buffer containing a final
concentration of 20 mM HEPES pH 7.4, 50 μM Ampliflu
Red, 0.1 U/mL horseradish peroxidase (HRP), 0.01% Tween
20, 0.01% Triton X 100, 0.01 mg/mL BSA, and 0.1 μM
fluorescein, unless stated otherwise. However, based on the
microfluidic chip function, solutions from assay and sample
sides are mixed at a ratio of 1 to 9. One must therefore make
use of suitably higher initial concentrations in the assay and
sample wells to ensure correct final concentrations inside the
chip. 10× concentrated Ampliflu Red, HRP, Tween 20, Triton
X 100, BSA, fluorescein, and enzyme were placed in the assay
inlet, whereas 1.1× concentrated fluorescein along with
substrates were placed in the sample inlets.
For capturing enzyme initial rates (Figure 1), five
concentrations of lactate oxidase (1, 5, 10, 20, and 50 mU/
mL) were assayed with 5 mM lactate in the buffer listed above
as well as buffers containing no BSA and 0.1% of the
detergents Tween 20 and Triton-X-100.
For obtaining kinetic constants, lactate oxidase from
Aerococcus viridans (product no. L9795), glucose oxidase
from Aspergillus niger (product no. G2133), and glutamate
oxidase from Streptomyces sp. (product no. G5921) were
assayed with lactate, glucose, and glutamate, respectively. The
final enzyme concentrations used, in duplicate, are as follows: 6
μg/mL, 1.2 μg/mL, 240 ng/mL, 48 ng/mL, 9.6 ng/mL, and 0
ng/mL. The following are the final substrate concentrations
used (inside reaction chambers): 100 mM, 33.33 mM, 11.11
mM, 3.7 mM, 1.23 mM, 412 μM, 137 μM, 47 μM, 15 μM, 5
μM, 1.7 μM, and 0 μM.
Enzyme Assays in Microplates. For kinetic constant
calculations, the final concentrations of enzymes and substrates
used were the same as for enzymatic assays in the Biomark HD
system (see above). The assays were performed in low-volume
384-well black flat bottom plates (Greiner) and the reaction
volume was 20 μL. The assay buffer contained 20 mM HEPES
pH 7.4, 50 μM Ampliflu Red, and 0.1 U/mL HRP. The assays
were started by the addition of substrate to the buffer-enzyme
mix and the readouts were carried out every 30 s for 30 min
with an excitation filter of 544 nm and an emission filter of 590
nm in a FLUOstar Omega microplate reader (BMG Labtech,
Germany).
Standard Curves. For obtaining a resorufin standard curve
for the Fluidigm system, nine resorufin dilutions were prepared
in 20 mM HEPES buffer, pH 7.4 with 0.11 μM fluorescein and
pipetted into the respective sample inlets, together with a no
resorufin control. The buffer containing 20 mM HEPES pH
7.4, 1.1 μM fluorescein, 0.11% Tween 20, 0.11% Triton X 100,
and 0.11 mg/mL BSA was placed in the assay inlets. Because of
the all versus all mixing of samples and assays inside the chip,
this results in multiple technical replicates for each
concentration. The final resorufin concentrations in the
microfluidic chambers were 10, 5, 2.5, 1.25, 0.625, 0.313,
0.156, 0.079, 0.04, and 0 μM.
For obtaining a resorufin standard curve using the FLUOstar
Omega microplate reader, nine resorufin dilutions were
prepared in triplicates in 20 mM HEPES buffer, pH 7.4,
together with a no resorufin control. The final resorufin
concentrations were 12.5, 6.25, 3.13, 1.56, 0.78, 0.39, 0.195,
0.097, 0.049, and 0 μM. Measurements were obtained using an
excitation filter of 544 nm and an emission filter of 590 nm.
Data Analysis. Data obtained from the Fluidigm instru-
ment were analyzed as follows. After a finished run, corners of
the chip were adjusted manually in Fluidigm’s Real-Time PCR
Analysis Software and the quantification of fluorescence
intensities in the ROX and FAM channels was carried out
automatically using software. The run data containing
fluorescence intensity values were exported in a *.csv format.
Two input files describing the sample layout on both “assay”
and “sample” sides were manually created. Custom scripts in R
version 3.4.4 (www.r-project.org) were used to analyze data.
Briefly, the resorufin fluorescence (ROX channel) was
background-subtracted and converted to product concen-
tration using a standard curve. Samples for which no activity
was observed (typically those with enzyme loading and low-
substrate concentrations) were removed. Regression models
were fitted to the linear range of data and the slopes were
calculated to obtain resorufin production per minute (μM
min−1). The enzyme specific activity (μmol mg−1 min−1) was
finally calculated using a reaction volume of 8.87 nL and the
protein concentration used in each reaction. Finally, the
enzyme concentration yielding the best linear model fit to the
activity data (greatest R2), as well as the highest Spearman
correlation between the substrate concentration and the
reaction rate, was automatically selected and fitted to the







. Scripts and raw data
are available at GitHub (https://github.com/EngqvistLab/
biomark_assays).
Data obtained from the FLUOstar Omega plate reader were
analyzed in the same manner as data from the Fluidigm
instrument. The only difference is that fluorescence intensities
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